DANIEL DOMINGUEZ: Open Payments
NPI 1720610447 · MIDLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,230 in 73 payments from 12 companies in 2025. Trend: 2023 $227 · 2024 $529 · 2025 $1,230
Food & beverage: $1,230
| Company | Payments | Amount |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | 24 | $244 |
| Janssen Biotech, Inc. | 15 | $236 |
| Madrigal Pharmaceuticals | 5 | $175 |
| Ardelyx, Inc. | 9 | $170 |
| PFIZER INC. | 4 | $98 |
| ABBVIE INC. | 5 | $97 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $91 |
| GENZYME CORPORATION | 2 | $37 |
| Phathom Pharmaceuticals, Inc. | 2 | $31 |
| Lilly USA, LLC | 1 | $24 |
Products named: IQIRVO, TREMFYA, REZDIFFRA, IBSRELA, VELSIPITY, ENTYVIO, SKYRIZI, DUPIXENT.
Industry payments across TX — which companies pay providers there.
